Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: Final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

1. Llombart-Cussac, A.
2. Ruiz, A.
3. Antón, A.
4. Barnadas, A.
5. Antolín, S.
6. Alés-Martínez, J.E.
7. Álvarez, I.
8. Andrés, R.
9. García Saenz, J.A.
10. Lao, J.
11. Carrasco, E.
12. Cámara, C.
13. Casas, I.
14. Martín, M.